The Immune Response and the Therapeutic Effect of Metronomic Chemotherapy With Cyclophosphamide
Metronomic chemotherapy (MCT) is a novel therapeutic strategy for cancer treatment endowed with an antiangiogenic effect. It refers to regular administration of low doses of cytotoxic drugs, with minimal or no drug-free breaks. Previously, we demonstrated the immunomodulating activity of a single...
Guardado en:
| Autores principales: | Rozados, Viviana R., Mainetti, Leandro Ernesto, Rico, María José, Zacarías Fluck, Mariano, Matar, Pablo, Scharovsky, O. Graciela |
|---|---|
| Formato: | article artículo publishedVersion |
| Lenguaje: | Inglés |
| Publicado: |
Cognizant Communication Corporation
2012
|
| Materias: | |
| Acceso en línea: | http://hdl.handle.net/2133/2011 http://dx.doi.org/10.3727/096504010X12777678141662 http://hdl.handle.net/2133/2011 |
| Aporte de: |
Ejemplares similares
-
Safety and therapeutic effect of metronomic chemotherapy with cyclophosphamide and celecoxib in advanced breast cancer patients
por: Perroud, Herman A, et al.
Publicado: (2018) -
Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
por: Perroud, Herman A, et al.
Publicado: (2018) -
Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response
por: Perroud, Herman A, et al.
Publicado: (2018) -
Association between baseline VEGF/sVEGFR-2 and VEGF/TSP-1 ratios and response to metronomic chemotherapy using cyclophosphamide and celecoxib in patients with advanced breast cancer
por: Perroud, Herman A, et al.
Publicado: (2018) -
Metronomic therapy with cyclophosphamide induces rat lymphoma and sarcoma regression, and is devoid of toxicity
por: Rozados, Viviana R., et al.
Publicado: (2012)